Acurx Pharmaceuticals, Inc. Reports Third Quarter 2022 Results and Provides Business Update
- Monday, November 14, 2022, 7:06
- Finance
- Add a comment
STATEN ISLAND, N.Y., Nov. 14, 2022 /PRNewswire/ — Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, announced today certain financial and…
About the Author
adminasapcorp has written 41811 stories on this site.